- Home
- EVER vs AQST Comparison
EVER vs AQST Comparison
Compare EVER & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVER
- AQST
- Stock Information
- Founded
- EVER 2008
- AQST 2004
- Country
- EVER United States
- AQST United States
- Employees
- EVER N/A
- AQST N/A
- Industry
- EVER Computer Software: Programming Data Processing
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EVER Technology
- AQST Health Care
- Exchange
- EVER Nasdaq
- AQST Nasdaq
- Market Cap
- EVER 929.6M
- AQST 809.3M
- IPO Year
- EVER 2018
- AQST 2018
- Fundamental
- Price
- EVER $24.27
- AQST $5.92
- Analyst Decision
- EVER Strong Buy
- AQST Strong Buy
- Analyst Count
- EVER 5
- AQST 6
- Target Price
- EVER $31.80
- AQST $10.33
- AVG Volume (30 Days)
- EVER 562.1K
- AQST 3.2M
- Earning Date
- EVER 11-03-2025
- AQST 11-05-2025
- Dividend Yield
- EVER N/A
- AQST N/A
- EPS Growth
- EVER 282.10
- AQST N/A
- EPS
- EVER 1.44
- AQST N/A
- Revenue
- EVER $644,656,000.00
- AQST $44,132,000.00
- Revenue This Year
- EVER $32.27
- AQST N/A
- Revenue Next Year
- EVER $11.05
- AQST $51.39
- P/E Ratio
- EVER $16.88
- AQST N/A
- Revenue Growth
- EVER 57.83
- AQST N/A
- 52 Week Low
- EVER $16.63
- AQST $2.12
- 52 Week High
- EVER $30.03
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- EVER 68.93
- AQST 42.16
- Support Level
- EVER $19.15
- AQST $6.39
- Resistance Level
- EVER $25.95
- AQST $6.93
- Average True Range (ATR)
- EVER 0.87
- AQST 0.37
- MACD
- EVER 0.62
- AQST -0.18
- Stochastic Oscillator
- EVER 76.31
- AQST 2.08
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.